Latest news with #Ambu
Yahoo
15-05-2025
- Business
- Yahoo
European Growth Companies With High Insider Ownership For May 2025
As of May 2025, European markets have shown resilience, with the pan-European STOXX Europe 600 Index rising for a fourth consecutive week amid optimism over easing trade tensions between China and the U.S. This positive sentiment is further buoyed by Germany's robust industrial output and recent monetary policy adjustments across several European countries. In such an environment, growth companies with high insider ownership can be particularly appealing to investors seeking alignment between management interests and shareholder value, as these traits may indicate confidence in the company's future prospects amidst evolving market dynamics. Name Insider Ownership Earnings Growth Pharma Mar (BME:PHM) 11.8% 43.1% KebNi (OM:KEBNI B) 38.3% 66.1% Yubico (OM:YUBICO) 36.5% 30.4% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Vow (OB:VOW) 13.1% 81% Elicera Therapeutics (OM:ELIC) 23.8% 97.2% CD Projekt (WSE:CDR) 29.7% 37.4% Elliptic Laboratories (OB:ELABS) 22.6% 51.9% Norbit (OB:NORBT) 13.2% 26.6% Nordic Halibut (OB:NOHAL) 29.7% 60.7% Click here to see the full list of 209 stocks from our Fast Growing European Companies With High Insider Ownership screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ambu A/S is a medical technology company that develops, produces, and sells medical devices to hospitals, clinics, and rescue services globally, with a market cap of DKK27.81 billion. Operations: The company's revenue is derived from Disposable Medical Products, amounting to DKK5.83 billion. Insider Ownership: 24.9% Earnings Growth Forecast: 24.8% p.a. Ambu A/S demonstrates strong growth prospects with earnings forecasted to increase by 24.8% annually, outpacing the Danish market's 7.7%. Recent financial results show robust performance, with second-quarter sales rising to DKK 1.55 billion and net income reaching DKK 188 million. Despite trading at a discount of 17.6% below its estimated fair value, Ambu's revenue is expected to grow at a rate of 10.2%, surpassing the broader market's pace of 8.2%. Click here and access our complete growth analysis report to understand the dynamics of Ambu. Insights from our recent valuation report point to the potential overvaluation of Ambu shares in the market. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Surgical Science Sweden AB (publ) specializes in developing and marketing virtual reality simulators for evidence-based medical training globally, with a market cap of SEK7.69 billion. Operations: The company's revenue is derived from two main segments: Industry/OEM, contributing SEK441.59 million, and Educational Products, accounting for SEK442.50 million. Insider Ownership: 14.8% Earnings Growth Forecast: 34.4% p.a. Surgical Science Sweden shows promising growth potential, with earnings forecasted to grow 34.4% annually, significantly outpacing the Swedish market's 16.4%. The company reported strong Q1 results with sales of SEK 250.69 million and net income of SEK 33.24 million, despite a decline in profit margins from last year. Trading at a substantial discount to its estimated fair value, it presents an attractive opportunity for investors focused on growth companies with high insider ownership levels in Europe. Unlock comprehensive insights into our analysis of Surgical Science Sweden stock in this growth report. Our expertly prepared valuation report Surgical Science Sweden implies its share price may be lower than expected. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Straumann Holding AG is a global provider of tooth replacement and orthodontic solutions, with a market capitalization of CHF17.99 billion. Operations: Straumann Holding AG generates revenue through its operations in various regions, including CHF1.32 billion from Operations, CHF0.59 billion from Sales in Asia Pacific (APAC), CHF0.79 billion from Sales in North America (NAM), CHF0.29 billion from Sales in Latin America (LATAM), and CHF1.11 billion from Sales in Europe, Middle East and Africa (EMEA). Insider Ownership: 32.3% Earnings Growth Forecast: 13.4% p.a. Straumann Holding demonstrates robust growth potential, with revenue forecasted to grow at 9.6% annually, surpassing the Swiss market's 4.2%. Recent innovations like the Straumann AXS platform enhance its digital workflow capabilities in dentistry. The appointment of Isabelle Adelt as CFO may strengthen financial strategy. Despite a high P/E ratio of 39.3x, slightly below industry average, insider ownership remains significant without recent substantial insider trading activity, supporting its position among European growth stocks with high insider involvement. Click here to discover the nuances of Straumann Holding with our detailed analytical future growth report. Our expertly prepared valuation report Straumann Holding implies its share price may be too high. Click this link to deep-dive into the 209 companies within our Fast Growing European Companies With High Insider Ownership screener. Contemplating Other Strategies? Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include CPSE:AMBU B OM:SUS and SWX:STMN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Reuters
14-05-2025
- Business
- Reuters
India's Shree Cement just misses profit view as higher costs bite into record sales volume
May 14 (Reuters) - India's Shree Cement ( opens new tab posted a fourth-quarter profit that fell just shy of analysts estimates on Wednesday, as record sales volumes were outweighed by higher expenses and a bigger tax bill. The company's net profit dropped about 16% to 5.56 billion rupees ($65.2 million), just below analysts' average expectation of 5.59 billion rupees, per data compiled by LSEG. In a seasonally strong quarter, Shree Cement's sales volumes hit a record 9.84 million tonnes, lifting revenue by 3% to 52.40 billion rupees, which exceeded analysts' expectations. However, its total costs rose about 5% to 46.48 billion rupees. Freight costs, which account for a quarter of the total expenses, jumped more than 10%. The company's tax expenses also went up 69%. For further earnings highlights, click KEY CONTEXT The weather in India during the January-March period is usually favourable for construction activities, which spurs demand for cement. Cement mills typically cash in on this by boosting their volumes. Prices also began to recover in the past few months, reversing from declines logged for the bulk of last year. However, the average all-India cement price for the January-March quarter was 2% lower on-year, data from brokerage Ambit Capital showed. As a result, the sector has furnished a mixed bag of results. Market leader UltraTech Cement ( opens new tab missed estimates on soft pricing while strong volumes boosted profits at rival Adani-owned Ambuja Cements ( opens new tab. PEER COMPARISON * The average of analysts ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell ** The ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT JANUARY-MARCH STOCK PERFORMANCE -- All data from LSEG -- $1 = 85.2625 Indian rupees
Yahoo
16-04-2025
- Business
- Yahoo
European Growth Stocks Insiders Are Investing In
In recent weeks, European markets have experienced heightened volatility due to escalating trade tensions, with major indices such as the STOXX Europe 600 Index seeing declines. Amid this uncertainty, growth companies with high insider ownership can present intriguing opportunities for investors, as insider investment often signals confidence in a company's long-term potential despite short-term market fluctuations. Name Insider Ownership Earnings Growth Pharma Mar (BME:PHM) 11.8% 40.8% Vow (OB:VOW) 13.1% 111.2% Elicera Therapeutics (OM:ELIC) 20.5% 97.2% Bergen Carbon Solutions (OB:BCS) 12% 50.8% CD Projekt (WSE:CDR) 29.7% 37.4% Devyser Diagnostics (OM:DVYSR) 35.7% 96.5% Elliptic Laboratories (OB:ELABS) 22.6% 88.2% Lokotech Group (OB:LOKO) 13.9% 58.1% Nordic Halibut (OB:NOHAL) 29.8% 60.7% Ortoma (OM:ORT B) 27.7% 68.6% Click here to see the full list of 216 stocks from our Fast Growing European Companies With High Insider Ownership screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ambu A/S is a medical technology company that develops, produces, and sells medical devices to hospitals, clinics, and rescue services globally, with a market capitalization of DKK31.41 billion. Operations: The company's revenue is primarily derived from its Disposable Medical Products segment, which generated DKK5.65 billion. Insider Ownership: 24.9% Ambu is poised for significant earnings growth, with forecasts indicating a 25.44% annual increase over the next three years, outpacing the Danish market's 8.4%. Despite trading at 9.3% below its estimated fair value and having no recent insider transactions, Ambu reported strong first-quarter results with sales of DKK 1.51 billion and net income of DKK 183 million, doubling from the previous year. However, its Return on Equity is expected to remain modest at 14.2%. Click to explore a detailed breakdown of our findings in Ambu's earnings growth report. According our valuation report, there's an indication that Ambu's share price might be on the expensive side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Surgical Science Sweden AB (publ) specializes in developing and marketing virtual reality simulators for evidence-based medical training globally, with a market cap of SEK6.67 billion. Operations: The company's revenue is derived from two main segments: Industry/OEM, contributing SEK441.59 million, and Educational Products, generating SEK442.50 million. Insider Ownership: 26.6% Surgical Science Sweden is set for robust growth, with earnings projected to rise 37.1% annually over the next three years, surpassing the Swedish market's 13.4%. Despite a decline in profit margins from 26.5% to 14.9%, revenue is forecasted to grow at a substantial rate of 19.7% per year. Recent expansion into defense markets through a US$4.7 million order underscores its strategic diversification efforts, though insider trading activity remains minimal over recent months. Take a closer look at Surgical Science Sweden's potential here in our earnings growth report. Our valuation report here indicates Surgical Science Sweden may be undervalued. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Straumann Holding AG offers tooth replacement and orthodontic solutions globally, with a market cap of CHF15.66 billion. Operations: The company generates revenue from several regions, with CHF1.32 billion from operations, CHF592.70 million from Asia Pacific, CHF791.79 million from North America, CHF290.28 million from Latin America, and CHF1.11 billion from Europe, the Middle East and Africa. Insider Ownership: 32.3% Straumann Holding's earnings are set to grow at 14.03% annually, outpacing the Swiss market's 11%. The company's revenue is also expected to rise faster than the market at 9.7% per year. Recent innovations like Straumann AXS enhance its digital workflow, potentially boosting growth prospects. Despite no significant insider trading activity recently, strategic leadership changes with Isabelle Adelt as CFO and Grant Bester overseeing North America could influence future performance positively. Dive into the specifics of Straumann Holding here with our thorough growth forecast report. Our expertly prepared valuation report Straumann Holding implies its share price may be too high. Click here to access our complete index of 216 Fast Growing European Companies With High Insider Ownership. Seeking Other Investments? Trump's oil boom is here — pipelines are primed to profit. Discover the 20 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include CPSE:AMBU B OM:SUS and SWX:STMN. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14-02-2025
- Business
- Yahoo
3 Growth Stocks Insiders Own With Up To 39% Earnings Growth
In a week marked by tariff uncertainties and mixed economic signals, global markets experienced volatility, with major U.S. indices ending lower despite some recovery efforts. Amid these fluctuations, investors are keenly observing earnings reports as a significant number of companies have surpassed expectations, highlighting the importance of strong financial performance in navigating current market challenges. In this environment, growth companies with substantial insider ownership can be particularly appealing due to their potential alignment between management and shareholder interests, providing an added layer of confidence in their strategic direction. Name Insider Ownership Earnings Growth Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) 17.3% 22.8% SKS Technologies Group (ASX:SKS) 29.7% 24.8% Propel Holdings (TSX:PRL) 36.5% 38.7% CD Projekt (WSE:CDR) 29.7% 39.4% Medley (TSE:4480) 34.1% 27.3% Pharma Mar (BME:PHM) 11.9% 45.4% Kingstone Companies (NasdaqCM:KINS) 20.8% 24.9% Elliptic Laboratories (OB:ELABS) 26.8% 121.1% Plenti Group (ASX:PLT) 12.7% 120.1% Findi (ASX:FND) 35.8% 111.4% Click here to see the full list of 1451 stocks from our Fast Growing Companies With High Insider Ownership screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ambu A/S is a medical technology company that develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide with a market cap of DKK35.91 billion. Operations: The company's revenue is primarily generated from its Disposable Medical Products segment, which amounts to DKK5.65 billion. Insider Ownership: 24.9% Earnings Growth Forecast: 25.6% p.a. Ambu A/S demonstrates robust growth potential, with earnings forecasted to rise 25.6% annually, outpacing the Danish market. Recent Q1 results showed sales of DKK 1.51 billion and net income of DKK 183 million, reflecting strong year-over-year growth. Despite low insider trading activity, insiders have purchased more shares than sold recently. The company's revenue is expected to grow at 11.1% annually, surpassing the market average but below significant thresholds for high growth companies. Click to explore a detailed breakdown of our findings in Ambu's earnings growth report. Upon reviewing our latest valuation report, Ambu's share price might be too optimistic. Simply Wall St Growth Rating: ★★★★★☆ Overview: Newborn Town Inc., with a market cap of HK$6.91 billion, operates as an investment holding company focused on the social networking business globally. Operations: The company's revenue primarily comes from its Social Networking Business, generating CN¥3.80 billion, alongside an Innovative Business segment contributing CN¥406.28 million. Insider Ownership: 22.1% Earnings Growth Forecast: 24.7% p.a. Newborn Town's earnings are forecast to grow significantly at 24.7% annually, surpassing the Hong Kong market average. Despite recent shareholder dilution, the company trades below its fair value and shows strong revenue growth potential, particularly in social networking driven by AI advancements and strategic acquisitions. Recent corporate guidance indicates a substantial increase in revenue for 2024. Board changes include appointing Ms. CHEN Sichao, enhancing expertise in innovative technologies amidst volatile share price movements. Click here and access our complete growth analysis report to understand the dynamics of Newborn Town. Upon reviewing our latest valuation report, Newborn Town's share price might be too pessimistic. Simply Wall St Growth Rating: ★★★★★☆ Overview: J&V Energy Technology Co., Ltd. operates in Taiwan through the development, investment, maintenance, and management of renewable energy plants, with a market cap of approximately NT$23.29 billion. Operations: The company's revenue segments are Solar Engineering (NT$627.60 million), Sale of Electricity (NT$945.51 million), Energy Storage Engineering (NT$1.15 billion), and Trading of Energy Equipment (NT$178.71 million). Insider Ownership: 19.6% Earnings Growth Forecast: 39.8% p.a. J&V Energy Technology is poised for substantial growth, with earnings expected to rise significantly at 39.8% annually, outpacing the Taiwan market. Despite recent shareholder dilution and a low return on equity forecast of 16.1%, the company anticipates revenue growth of 31.3% per year, well above market averages. Recent developments include a completed share buyback program and an acquisition by Abonmax Co., Ltd for approximately TWD 170 million, potentially impacting future strategic direction. Navigate through the intricacies of J&V Energy Technology with our comprehensive analyst estimates report here. Our valuation report unveils the possibility J&V Energy Technology's shares may be trading at a premium. Reveal the 1451 hidden gems among our Fast Growing Companies With High Insider Ownership screener with a single click here. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include CPSE:AMBU B SEHK:9911 and TWSE:6869. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Associated Press
27-01-2025
- Health
- Associated Press
Nonprofit Seeks Volunteers for Cervical Cancer Prevention Mission in Guatemala
Madre y Niño, a nonprofit organization dedicated to improving healthcare outcomes in rural Guatemala, is now accepting volunteer applications for its upcoming mission trip to the Petén region from Sunday, March 9, 2025, through Saturday, March 15, 2025. The life-saving trip will specifically target Laguna del Tigre, a remote rainforest bordering Mexico. Volunteers will assist in cervical cancer prevention efforts for 400 women in collaboration with local health authorities and medical professionals. The cost to participate is $800, which covers transportation, lodging, and meals. Airfare is separate. The deadline to apply is February 9, 2025, with a max of 10 volunteers allowed for this trip. Cervical cancer is the leading cause of cancer-related deaths among Guatemalan women, with 3.77 million Guatemalan women currently at risk for this potentially fatal cancer according to Guatemala's National Cancer Institute. Studies show women feel more comfortable working with midwives, trusted leaders in their communities. 'By empowering these dedicated providers with knowledge and supplies, Madre y Niño is creating a ripple effect that is improving health outcomes in some of the most underserved areas of Guatemala,' said Deborah Bell, president of Madre y Niño and a family practice nurse practitioner (FNP) from Longview, Texas. For the past five years, Madre y Niño has worked alongside local communities and health agencies to provide education and essential resources for lay midwives, the primary healthcare providers for most rural births. With a focus on improving maternal and child health, the organization has educated nearly 200 lay midwives through four separate learning sessions. These sessions have covered vital topics such as recognizing obstetric emergencies, neonatal resuscitation, COVID-19 protocols, and preeclampsia detection—the second leading cause of maternal death in Guatemala. The lay midwives, who are highly respected community leaders despite lacking formal training and supplies, are equipped with life-saving tools, including bulb suctions, Ambu bags, stethoscopes, and blood pressure cuffs, during these sessions. In addition to educational support, the organization has also delivered essential birth supplies during these sessions, such as exam gloves, umbilical cord clamps, iodine, and soap, ensuring midwives have the tools they need to support safe deliveries. Madre y Niño has published findings from these sessions in peer-reviewed journals like Birth and Hispanic Health Care International, and presented research at prestigious international conferences, including the International Confederation of Midwives in Bali, Indonesia, and Eurogin in Bilbao, Spain. Founded by a dedicated group of bilingual nurses and healthcare professionals with strong ties to Texas, Madre y Niño is led by Deborah Bell, whose decades of experience in global healthcare and volunteer work in Guatemala earned her the moniker 'Mother Teresa of Guatemala.' Bell co-founded Refugee International, which has operated healthcare clinics in Guatemala since 2003. Other key leaders of Madre y Niño include VP Kimberly Garcia, a Doctor of Nursing Practice (DNP) and certified nurse midwife; Treasurer Michelle Solis, a registered nurse and former lay midwife; Secretary Bob Kahn, a journalist and author; and Malia Knight, registered nurse. Additionally, the organization's board of directors is made up of healthcare professionals and advocates, including obstetrician-gynecologist Dr. Chris Yancey, physician assistant Patty Stephens, pediatric nurse practitioner Teri Grothaus, and attorney Claire Earnest. Each board member brings invaluable expertise in maternal health, child welfare, global health, and social justice, helping guide Madre y Niño's continued efforts to make healthcare accessible to Guatemala's most vulnerable populations. Madre y Niño is committed to expanding its reach, both through educational programs for lay midwives and through direct healthcare missions in underserved areas. The organization invites donations, partnerships, and volunteers to help support their mission. Interested parties can contribute by donating funds, purchasing backpacks with birth supplies for lay midwives, buying HPV tests, or volunteering during the organization's educational sessions or healthcare missions. For more information about Madre y Niño or to get involved, please visit About Madre y Niño Madre y Niño is a nonprofit organization dedicated to improving maternal and child health in rural Guatemala. Through education, resource distribution, and healthcare outreach, the organization empowers local communities to enhance health outcomes and provides critical healthcare services to underserved populations. Founded by a group of experienced healthcare professionals, Madre y Niño works closely with local health authorities to address some of the country's most pressing healthcare challenges. Contact Information: Francis Mariela 239-273-6976
